Fact CheckerSign in

NCT07509853Recruiting

Integrating Sexual Pleasure Into Harm Reduction Services for Men Who Have Sex With Men and Transgender Persons Who Engage in Chemsex or Substance Use in Thailand

Source: ClinicalTrials.gov · Last updated 8 Apr 2026

Brief summary (registry, in English)

The study evaluates the integration of a sexual pleasure-based approach into harm reduction services for MSM and transgender persons engaging in chemsex or substance use in Thailand, using the "Pleasuremeter" tool to improve sexual health and related outcomes.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
300 (estimated)
First submitted
22 Mar 2026
Start date
1 May 2025
Primary completion date
1 May 2027
Lead sponsor
Institute of HIV Research and Innovation Foundation, Thailand
Diseases
HIV
NCT number
NCT07509853

What you commit to

  • Study type: Interventional
  • Planned participants: 300
  • From 1 May 2025 to the primary completion date, 1 May 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Unable to communicate in Thai sufficiently to complete study procedures

Who the study is looking for

  • MSM, transgender women, transgender men, or non-binary persons
  • Age ≥18 years
  • Engaged in chemsex or substance use within past 12 months
  • Able to provide informed consent

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Tangerine Clinic, Institute of HIV Research and Innovation
Coordinator of this site? Confirm its status
Pathum WanThailandRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.